Pilocarpine used to treat xerostomia in patients submitted to radioactive iodine therapy: A pilot study

Brazilian Journal of Otorhinolaryngology

Volumn 76, Issue 5, 2010, Pages 659-662

  Almeida, Juliana Pereira ^b   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b NONE

Author keywords

Iodine; Pilocarpine; Thyroid neoplasms; Xerostomia

Indexed keywords

PILOCARPINE; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG THERAPY; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; PROSPECTIVE STUDY; SALIVARY GLAND; SALIVATION; SCINTISCANNING; THYROID TUMOR; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; PILOCARPINE; PILOT PROJECTS; PROSPECTIVE STUDIES; SALIVARY GLANDS; SALIVATION; THYROID NEOPLASMS; TREATMENT OUTCOME; XEROSTOMIA;

EID: 79952201695     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1590/S1808-86942010000500021     Document Type: Article

References (17)

1. Newkirk KA, Ringel MD, Wartofsky L, Burman KD. The role of radioactive iodine in salivary gland dysfunction. Ear Nose Throat J. 2000; 79(6): 460-468.
2. Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med. 1998; 39(9): 1551-1554.
3. Bushnell DL, Boles MA, Kaufman GE, Wadas MA, Barnes E. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma. J Nucl Med. 1992; 33(12): 2214-2221.
4. Jensen SB, Pedersen AM, Reibel J, Nauntofte B. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer. 2003; 11(4): 207-225.
5. Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002; 27(11): 767-71.
6. Koseki M, Maki Y, Matsukubo T, Ohashi Y, Tsubota K. Salivary flow and its relationship to oral signs and symptoms in patients with dry eyes. Oral Dis. 2004; 10(2):75-80.
7. Fox PC. Salivary enhancement therapies. Caries Res. 2004; 38(3): 241-246.
8. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol. 1993; 11(6): 1124-1131.
9. Hamlar DD, Schuller DE, Gahbauer RA, Buerki RA, Staubus AE, Hall J, et al. Determination of the efficacy of topical oral pilocarpine for postradiation xerostomia in patients with head and neck carcinoma. Laryngoscope. 1996; 106(8): 972-976.
10. Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocar-pine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys. 1997; 37(3): 571-575.
11. Horiot JC, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet M, et al. Post-radiation severe xerostomia relieved by pilo-carpine: a prospective French cooperative study. Radiother Oncol. 2000; 55(3): 233-239.
12. Leek H, Albertsson M. Pilocarpine treatment of xerostomia in head and neck patients. Micron. 2002; 33(2): 153-155.
13. Haddad P, Karimi M. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol. 2002; 64(1): 29-32.
14. Gorsky M, Epstein JB, Parry J, Epstein MS, Le ND, Silverman S Jr. The efficacy of pilocarpine in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol. 2004; 97(2): 190-195.
15. Mosqueda-Taylor A, Luna-Ortiz K, Irigoyen-Camacho ME, Díaz-Franco MA, Coll-Muñoz AM. Efecto del clorhidrato de pilocarpina como estimulante de la producción salival en pacientes sometidos a radioterapia de cabeza y cuello. Med Oral. 2004; 9(3): 204-211.
16. Silberstein EB. Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine. J Nucl Med. 2008; 49(4): 546-549.
17. Aframian DJ, Helcer M, Livni D, Markitziu A. Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer. Oral Dis. 2006; 12(3): 297-300.